In this episode of Thoroughly Thriving, we welcome Jill Herendeen, a seasoned regulatory professional, to explore the intricate world of drug development and regulatory affairs. With over two decades of experience, Jill shares her insights on navigating the complex landscape of regulatory strategies, particularly for early-stage biotech companies. Join Darren, Sean, and Jill as they discuss:

• The importance of beginning with the end in mind when developing regulatory roadmaps
• How to effectively collaborate with the FDA and other regulatory bodies
• Key strategies for startups to manage their regulatory needs while maintaining financial prudence
• The critical role of data in shaping regulatory narratives and commercial preparations
• Insights into the current regulatory environment and its implications for drug innovationJill emphasizes the need for a holistic approach, reminding us that regulatory affairs are not just about compliance but also about serving unmet patient needs. Whether you're a startup founder or a seasoned professional, this episode is packed with valuable advice that can help you thrive in the biopharmaceutical industry.

🌟 Don’t miss this enlightening conversation!

🔔 Subscribe for more insightful discussions: 

📢 Follow us on LinkedIn:  https://www.linkedin.com/company/thorough-group/

#RegulatoryAffairs #DrugDevelopment #Biotech #ThoroughlyThrivingPodcast #FDA #Innovation